{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:15:39Z","timestamp":1774620939755,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.revmed.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T08:01:11Z","timestamp":1680249671000},"page":"307-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Manifestations rares des gammapathies monoclonales\u00a0: \u00e0 propos de 2\u00a0cas et revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"44","author":[{"given":"Q.","family":"Perlot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-C.","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.revmed.2023.03.005_bib0090","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.revmed.2023.03.005_bib0095","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.005_bib0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ejim.2009.01.001","article-title":"Systemic manifestations of monoclonal gammopathy","volume":"20","author":"Decaux","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"14","key":"10.1016\/j.revmed.2023.03.005_bib0105","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.revmed.2023.03.005_bib0110","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.005_bib0115","first-page":"345","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Throm Haemost"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.005_bib0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MD.0b013e3182397166","article-title":"Acquired von Willebrand syndrome associated with monoclonal gammopathy: a single-center study of 36\u00a0patients","volume":"90","author":"Voisin","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"10.1016\/j.revmed.2023.03.005_bib0125","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2023.03.005_bib0130","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0049-3848(13)70003-3","article-title":"Diagnosis and treatment of acquired von Willebrand syndrome","volume":"130","author":"Tiede","year":"2012","journal-title":"Thrombosis Res"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.005_bib0135","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/hae.14648","article-title":"Acquired von Willebrand syndrome and lymphoid neoplasms: a review of malignancy management, and propositions of practical recommendations","volume":"28","author":"Nicol","year":"2022","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.revmed.2023.03.005_bib0140","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.revmed.2020.06.010","article-title":"Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment","volume":"41","author":"Gobert","year":"2020","journal-title":"Rev Med Interne"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.005_bib0145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/07853890.2016.1162909","article-title":"Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment","volume":"48","author":"Zeerleder","year":"2016","journal-title":"Ann Med"},{"issue":"9","key":"10.1016\/j.revmed.2023.03.005_bib0150","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.revmed.2014.01.008","article-title":"Urticaria: diagnosis and treatment","volume":"35","author":"Soria","year":"2014","journal-title":"Rev Med Interne"},{"issue":"12","key":"10.1016\/j.revmed.2023.03.005_bib0155","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med"},{"issue":"33","key":"10.1016\/j.revmed.2023.03.005_bib0160","doi-asserted-by":"crossref","first-page":"e4363","DOI":"10.1097\/MD.0000000000004363","article-title":"A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment response in 92\u00a0patients","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.005_bib0165","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3324\/haematol.10769","article-title":"Lymphoproliferative disease and acquired C1\u00a0inhibitor deficiency","volume":"92","author":"Castelli","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.005_bib0085","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jaip.2021.01.040","article-title":"Efficacy of Lanadelumab in acquired angioedema with C1-inhibitor deficiency","volume":"9","author":"Belb\u00e9zier","year":"2021","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:43Z","timestamp":1759337203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866323000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0248866323000887"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2023.03.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations rares des gammapathies monoclonales\u00a0: \u00e0 propos de 2\u00a0cas et revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}